Page 3 - Stock Movemnet

Here's why Biocon shares were trading higher on the bourses on October 20

Biocon Biologics, a fully integrated global biosimilars company and a subsidiary of Biocon, announced the expansion of its strategic collaboration with Civica, Inc. (Civica)

Ola Electric shares ride 5% on bourses; here's what is driving the rally

Earlier, on Thursday, October 16, the stock had hit the upper circuit of 5 per cent following the announcement of the launch of Ola शक्ति, its first residential Battery Energy Storage System (BESS)

Here's why Nuvama sees a strong second half for JSW Infrastructure in FY26

The brokerage has pegged a December 2026 target price of ₹360 per share, based on a 22x EV/Ebitda multiple for December 2027

Kajaria's Q2 polish impresses, while demand cracks remain; analysts weigh

Emkay remains upbeat on Kajaria Ceramics, reiterating its Buy call, while Nuvama Institutional Equities takes a more measured stance, maintaining a Hold rating on the shares

Kajaria Ceramics shares rise over 2% on Q2 results, dividend announcement

Kajaria Ceramics' net profit advanced 58 per cent to ₹133 crore in Q2FY26 from ₹84 crore reported in the corresponding quarter of the previous fiscal year

Mangalore Refinery and Petrochemicals shares soar 9% on Q2 results; details

Mangalore Refinery and Petrochemicals share price zoomed 8.83 per cent to log an intra-day high of ₹154.55 per share on the BSE on Thursday

Here's why Godavari Biorefineries shares were locked in a 10% upper circuit

The northward movement in Godavari Biorefineries' share price came following the news that the company's patent application from its Anti-Cancer Research Segment has been granted in Europe

Adani Green Energy shares gain 2% on H1FY26 business update; details here

Adani Green Energy announced that its operational capacity rose 49 per cent year-on-year (Y-o-Y) to 16.7 GW as of H1FY26. Greenfield capacity additions stood at 2.4 GW

Nuvama retains Buy on Hyundai India; expects steady growth with EV, hybrids

Nuvama has maintained its 'Buy' rating on Hyundai Motor India shares with a target price of ₹3,200, valuing the stock at 33x Sep-27E core EPS plus ₹119 per share in cash

Paytm set to grow, says Axis Securities; upgrades to 'Buy', stock rises 3%

The analysts believe that large merchant payment providers, including Paytm, are entering a robust earnings growth phase

₹2,500-cr order from BHEL sends Power Mech shares up by 5%; details inside

Power Mech shares gained over 5 per cent after the company announced it had secured a ₹2,500 crore order from Bharat Heavy Electricals Limited (BHEL)

Here's why L&T Finance shares advanced over 2% in trade despite weak market

The northward movement in L&T Finance's share price came on the back of its announcement that it has made the allotment of non-convertible debentures (NCDs) worth ₹1,050 crore

Tata Capital debut: Emkay Global bullish on brand, diversified growth play

The brokerage has initiated coverage on Tata Capital with an 'Add' rating and a September 2026 target price of ₹360, implying a 10 per cent upside over the issue price of ₹326 per share

Here's what drove ACME Solar Holdings shares to a 52-week high in trade

ACME Solar Holdings, which listed on the NSE at ₹251 on November 13, 2024, is now trading 25 per cent above its listing price

Raining dividends on D-Street: 113 stocks go ex-date next week; full list

Here is the complete list of stocks that will trade ex-dividend next week, along with their announcement details and record dates

Here's why Kaynes Technology shares were in focus during today's trade

Shares of Kaynes Technology India have appreciated nearly 8 per cent in the last one month, 64 per cent in the past six months, and 43 per cent over the last one year

Biocon shares gain 2% after USFDA inspection at Bengaluru facility; details

The inspection covered various aspects of operations including drug substance manufacturing units, analytical quality control laboratories, microbiology laboratories, and warehouses

Herbal medicine firm Regencell Bioscience skyrockets 60,000%, stuns market

A Hong Kong-based herbal medicine firm with 12 employees is now worth $39 billion. Why Regencell Bioscience sparked a 60,000% YTD stock surge?

Solar Industries shares gain 5% on Q4 results, dividend call; details here

During Q4FY25, Solar Industries' profit after tax (PAT) climbed 42 per cent year-on-year (Y-o-Y) to ₹346 crore from ₹243 crore reported in the corresponding quarter of the previous fiscal year

Restaurant Brands Asia rallies 9% on Q4 results; check full details here

During the Q4FY25, the company's consolidated net loss reduced to ₹ 60.44 crore from a net loss of ₹ 92.09 crore reported in the corresponding quarter of the previous fiscal year (Q4FY24)